Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Cell Stress | journal | 1.517 Q1 | 27 | 22 | 123 | 1172 | 662 | 123 | 6.83 | 53.27 | 44.44 | |
52 | Seminars in Radiation Oncology | journal | 1.467 Q1 | 103 | 46 | 123 | 3233 | 685 | 114 | 5.22 | 70.28 | 33.56 | |
53 | Neoplasia | journal | 1.424 Q1 | 144 | 114 | 279 | 6238 | 1722 | 277 | 6.07 | 54.72 | 41.99 | |
54 | Oral Oncology | journal | 1.421 Q1 | 137 | 432 | 1064 | 11788 | 4706 | 753 | 4.12 | 27.29 | 34.97 | |
55 | Genes Chromosomes and Cancer | journal | 1.417 Q2 | 130 | 89 | 256 | 3992 | 1300 | 247 | 4.86 | 44.85 | 45.20 | |
56 | Endocrine-Related Cancer | journal | 1.416 Q2 | 146 | 106 | 361 | 6383 | 2149 | 345 | 6.05 | 60.22 | 48.13 | |
57 | Breast Cancer Research and Treatment | journal | 1.407 Q2 | 177 | 466 | 1397 | 16741 | 6300 | 1296 | 4.20 | 35.92 | 53.28 | |
58 | Cell Death Discovery | journal | 1.399 Q2 | 58 | 368 | 350 | 17084 | 2117 | 333 | 6.67 | 46.42 | 41.47 | |
59 | Lung Cancer | journal | 1.399 Q2 | 148 | 325 | 997 | 9998 | 5486 | 904 | 5.40 | 30.76 | 35.88 | |
60 | Cancer Research and Treatment | journal | 1.359 Q2 | 58 | 126 | 414 | 3587 | 2130 | 413 | 5.10 | 28.47 | 37.95 | |
61 | Cancers | journal | 1.349 Q2 | 133 | 6342 | 6394 | 515698 | 42531 | 6261 | 6.47 | 81.31 | 44.90 | |
62 | Cellular oncology (Dordrecht) | journal | 1.326 Q2 | 58 | 89 | 194 | 6059 | 1305 | 189 | 6.84 | 68.08 | 45.78 | |
63 | Journal of global oncology | journal | 1.313 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
64 | JCO Global Oncology | journal | 1.302 Q2 | 39 | 193 | 616 | 6350 | 2076 | 547 | 3.77 | 32.90 | 42.15 | |
65 | Experimental Hematology and Oncology | journal | 1.301 Q2 | 42 | 58 | 101 | 3483 | 670 | 100 | 7.16 | 60.05 | 39.63 | |
66 | Epigenetics | journal | 1.296 Q2 | 111 | 79 | 299 | 4644 | 1597 | 299 | 5.10 | 58.78 | 47.15 | |
67 | Frontiers in Oncology | journal | 1.291 Q2 | 136 | 5851 | 4942 | 315606 | 29148 | 4841 | 5.47 | 53.94 | 42.09 | |
68 | Experimental Hematology | journal | 1.241 Q2 | 129 | 80 | 274 | 4564 | 912 | 271 | 2.99 | 57.05 | 44.69 | |
69 | Targeted Oncology | journal | 1.233 Q2 | 59 | 67 | 218 | 2758 | 1001 | 212 | 4.73 | 41.16 | 41.83 | |
70 | Cancer Gene Therapy | journal | 1.207 Q2 | 99 | 98 | 163 | 5506 | 852 | 155 | 5.37 | 56.18 | 45.13 | |
71 | Clinical Lung Cancer | journal | 1.202 Q2 | 74 | 202 | 499 | 6823 | 2294 | 463 | 4.62 | 33.78 | 35.51 | |
72 | Journal of Immunotherapy | journal | 1.182 Q2 | 106 | 52 | 149 | 1641 | 723 | 148 | 4.76 | 31.56 | 43.33 | |
73 | Carcinogenesis | journal | 1.178 Q2 | 223 | 156 | 490 | 7432 | 2375 | 471 | 4.25 | 47.64 | 38.61 | |
74 | Breast | journal | 1.162 Q2 | 98 | 167 | 497 | 6088 | 2088 | 459 | 3.86 | 36.46 | 50.00 | |
75 | Virus Research | journal | 1.154 Q2 | 144 | 279 | 746 | 14221 | 4040 | 738 | 6.34 | 50.97 | 42.80 | |
76 | Tumour Virus Research | journal | 1.146 Q2 | 34 | 14 | 116 | 1387 | 534 | 109 | 4.62 | 99.07 | 45.68 | |
77 | Cancer Medicine | journal | 1.144 Q2 | 84 | 802 | 2176 | 30919 | 10517 | 2171 | 4.64 | 38.55 | 39.82 | |
78 | BMC Cancer | journal | 1.134 Q2 | 160 | 1320 | 3727 | 51492 | 18083 | 3726 | 4.52 | 39.01 | 39.02 | |
79 | Cancer cytopathology | journal | 1.133 Q2 | 68 | 125 | 369 | 3116 | 1230 | 250 | 3.30 | 24.93 | 46.42 | |
80 | Current Hematologic Malignancy Reports | journal | 1.125 Q2 | 44 | 53 | 170 | 3498 | 753 | 170 | 4.33 | 66.00 | 42.07 | |
81 | Genes and Cancer | journal | 1.121 Q2 | 81 | 9 | 43 | 340 | 210 | 42 | 2.75 | 37.78 | 38.78 | |
82 | Clinical and Experimental Metastasis | journal | 1.108 Q2 | 109 | 49 | 180 | 2969 | 829 | 167 | 4.13 | 60.59 | 41.81 | |
83 | International Journal of Oncology | journal | 1.105 Q2 | 139 | 139 | 926 | 10354 | 5305 | 926 | 5.61 | 74.49 | 37.95 | |
84 | Cancer Cell International | journal | 1.099 Q2 | 80 | 668 | 1113 | 36277 | 6711 | 1113 | 6.11 | 54.31 | 41.46 | |
85 | Stem Cell Reviews and Reports | journal | 1.078 Q2 | 87 | 182 | 256 | 14188 | 1585 | 237 | 6.75 | 77.96 | 45.08 | |
86 | Molecular Carcinogenesis | journal | 1.075 Q2 | 107 | 71 | 477 | 3390 | 2414 | 476 | 4.82 | 47.75 | 44.19 | |
87 | Differentiation | journal | 1.069 Q2 | 107 | 23 | 121 | 2191 | 429 | 117 | 3.04 | 95.26 | 29.35 | |
88 | Translational Oncology | journal | 1.060 Q2 | 72 | 353 | 510 | 18268 | 2428 | 508 | 4.79 | 51.75 | 39.50 | |
89 | Journal of Cancer Research and Clinical Oncology | journal | 1.058 Q2 | 109 | 346 | 814 | 14093 | 3811 | 794 | 4.68 | 40.73 | 37.19 | |
90 | Angiogenesis | journal | 1.056 Q2 | 101 | 57 | 155 | 3881 | 1298 | 150 | 8.65 | 68.09 | 39.30 | |
91 | Cancer journal (Sudbury, Mass.) | journal | 1.027 Q2 | 102 | 72 | 196 | 5096 | 641 | 178 | 1.92 | 70.78 | 45.64 | |
92 | Current Opinion in Oncology | journal | 1.022 Q2 | 104 | 97 | 241 | 4409 | 954 | 227 | 3.82 | 45.45 | 41.41 | |
93 | Journal of Neuro-Oncology | journal | 1.022 Q2 | 135 | 243 | 975 | 9333 | 4240 | 935 | 4.25 | 38.41 | 34.11 | |
94 | Apoptosis : an international journal on programmed cell death | journal | 1.017 Q2 | 128 | 51 | 202 | 3663 | 977 | 191 | 4.95 | 71.82 | 47.04 | |
95 | Cytotherapy | journal | 1.004 Q2 | 105 | 119 | 332 | 6022 | 1714 | 309 | 4.99 | 50.61 | 43.23 | |
96 | Cancer Prevention Research | journal | 0.996 Q2 | 112 | 118 | 314 | 5230 | 989 | 284 | 2.79 | 44.32 | 48.65 | |
97 | World Journal of Oncology | journal | 0.984 Q2 | 10 | 25 | 29 | 890 | 139 | 27 | 4.79 | 35.60 | 31.29 | |
98 | Hematological Oncology | journal | 0.971 Q2 | 54 | 113 | 350 | 3239 | 1029 | 277 | 3.08 | 28.66 | 47.90 | |
99 | Journal of the National Cancer Institute. Monographs | journal | 0.958 Q2 | 95 | 19 | 39 | 1226 | 172 | 36 | 4.41 | 64.53 | 49.15 | |
100 | Cancer Epidemiology | journal | 0.957 Q2 | 86 | 139 | 481 | 5939 | 1415 | 459 | 2.78 | 42.73 | 51.81 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®